Form 8-K - Current report:
SEC Accession No. 0001023024-07-000011
Filing Date
2007-10-24
Accepted
2007-10-24 11:22:48
Documents
1
Period of Report
2007-10-22
Items
Item 3.01: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing

Document Format Files

Seq Description Document Type Size
1 BIOSANTE MOVE TO NASDAQ movetonasdaq.htm 8-K 19062
  Complete submission text file 0001023024-07-000011.txt   20709
Mailing Address 111 BARCLAY BLVD STE 280 LINCOLNSHIRE IL 60069
Business Address 111 BARCLAY BLVD STE 280 LINCOLNSHIRE IL 60069 8474780500
BIOSANTE PHARMACEUTICALS INC (Filer) CIK: 0001023024 (see all company filings)

EIN.: 582301143 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-31812 | Film No.: 071187262
SIC: 2836 Biological Products, (No Diagnostic Substances)